Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice

Reduced function of the N -methyl- d -aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. The NMDAR contains a glycine binding site in its NR1 subunit that may be a useful target for the treatment of schizophrenia. In this study, we assessed the therapeutic potential of long-term increases in the brain levels of the endogenous NMDAR glycine site agonist D-serine, through the genetic inactivation of its catabolic enzyme D-amino acid oxidase (DAO) in mice. The effects of eliminating DAO function were investigated in mice that display schizophrenia-related behavioral deficits due to a mutation ( Grin 1 ^D481N ) in the NR1 subunit that results in a reduction in NMDAR glycine affinity. Grin 1 ^D481N mice show deficits in sociability, prolonged latent inhibition, enhanced startle reactivity and impaired spatial memory. The hypofunctional Dao 1 ^G181R mutation elevated brain levels of D-serine, but alone it did not affect performance in the behavioral measures. Compared to animals with only the Grin 1 ^D481N mutation, mice with both the Dao1 ^G181R and Grin 1 ^D481N mutations displayed an improvement in social approach and spatial memory retention, as well as a reversal of abnormally persistent latent inhibition and a partial normalization of startle responses. Thus, an increased level of D-serine resulting from decreased catalysis corrected the performance of mice with deficient NMDAR glycine site activation in behavioral tasks relevant to the negative and cognitive symptoms of schizophrenia. Diminished DAO activity and elevations in D-serine may serve as an effective therapeutic intervention for the treatment of psychiatric symptoms.     

Copper binding to chicken and human prion protein amylodogenic regions: Differences and similarities revealed by Ni as a diamagnetic probe

Both human (h) and chicken (Ch) prion proteins (PrP) bind copper ions within the so called “tandem repeat” N-terminal region. Outside this region, hPrP possesses two additional copper binding sites, localized at His-96 and His-111 in the so called “amylodogenic” or neurotoxic region (residues 91-126). Also ChPrP possesses a similar region (ChPrP_105−140) containing two His (His-110 and His-124) and an identical hydrophobic tail of 15 amino acids rich in Ala and Gly. The copper binding abilities within such region of ChPrP were investigated by NMR, CD and potentiometry using Ni²⁺ as diamagnetic probe. The formation of diamagnetic metal complexes allowed to monitor the chemical shift and signal intensity variations and to determine the structural and kinetic features of the His-110 and His-124 metal binding sites. Finally a comparison between the hPrP and ChPrP metal binding abilities was performed. We found that the two prion proteins exhibited different copper and nickel preferences with the favoured metal binding sites localized at opposite His: His-110 for ChPrP, and His-111 for hPrP.     

Dinuclear triply bridged copper(II)-carboxylato compounds with different bischelating ligands: Synthesis, crystal structure, spectroscopic and magnetic properties

Three new triply bridged dinuclear copper(II) compounds containing carboxylato bridges, [Cu₂(μ-CH₃COO-κ-O¹,O²)₂(μ-CH₃COO-κ-O¹)(dpyam)₂](BF₄) (1), [Cu₂(μ-CH₂CH₃COO-κ-O¹,O²)(μ-OH)(μ-OH₂)(bpy)₂](ClO₄)₂ (2) and [Cu₂(μ-CH₃COO-κ-O¹,O²)(μ-OH)(μ-OH₂)(phen)₂](ClO₄)₂ (3) (in which dpyam = di-2-pyridylamine, bpy = 2,2-bipyridine, phen = phenanthroline), have been synthesized in order to investigate the magnetic super-exchange pathway between coupled copper(II) centres. All three compounds display a distorted square-pyramidal arrangement around each copper(II) ion with a CuN₂O₃ chromophore. Compound 1 has three acetato bridges, two of which connect each square pyramid at two equatorial sites in a triatomic bridging mode and the third acetato bridge acts at the apical site in the monoatomic bridging mode. The structures of compounds 2 and 3 are mutually similar. In each dinuclear unit, both copper(II) ions are linked at two equatorial positions through a hydroxo bridge and a triatomic carboxylato bridge and at the axial position through a water molecule.The magnetic susceptibility measurements, measured from 5 to 300 K, revealed an antiferromagnetic interaction between the Cu(II) ions in compound 1 and a ferromagnetic interaction for compounds 2 and 3 with singlet-triplet energy gaps (J) of −56, 149 and 120 cm⁻¹, for compounds 1, 2 and 3, respectively.     

Mechanisms and functions of nonphosphorylating electron transport in respiratory chain of plant mitochondria

Data are raeviewed on mitochondrial systems whose functioning in plants diminishes the efficiency of oxidative phosphorylation. The involvement in this process of alternative oxidase, thermogenin-like uncoupling proteins, a 310 kD stress protein, free fatty acids, and the ADP/ATP antiporter is considered. The role of these systems is discussed with regard to thermogenesis, controlled production of reactive oxygen species, and regulation of bioenergetics and metabolism.     

Synthesis and structures of copper and gold complexes of the P,N ligands RNC(Bu)C(H)RPPh2 (R = SiMe3, H)

The reaction of the chelating P,N ligand RNC(Bu^t)CH(R)PPh₂ (R = SiMe₃) (1) with CuCl and CuCl₂ (probably by way of reduction to Cu(I) by the phosphine ligand) or Cu(NCCH₃)₄ClO₄ yielded the dimeric 1:1 complex [Cu{PPh₂CH(R)C(Bu^t)NR}Cl]₂ (2) or the monomeric 2:1 complex [Cu{PPh₂CH(R)C(Bu^t)NR}₂]ClO₄ (3), respectively. The presence of trace amounts of water during the reaction resulted in the successive cleavage of the two trimethylsilyl groups of the ligand and the formation of the monomeric chelate complexes [Cu{PPh₂CH(R)C(Bu^t)NH}₂]ClO₄ (4) and [Cu{PPh₂CH₂C(Bu^t)NH}₂]ClO₄ (5). Oxidation of 5 by atmospheric oxygen led to small quantities of the blue Cu(II) complex [Cu{(O)PPh₂CH₂C(Bu^t)NH}₂](ClO₄)₂ (6). The dimeric gold complexes [Au{PPh₂CH₂C(Bu^t)NH}]₂X₂ (X = BF₄, ClO₄) (7) were similarly obtained from the previously described Au{PPh₂CH(R)C(Bu^t)NR}Cl by replacing the covalently bound chlorine with the weakly coordinating anions in the presence of small quantities of water. The solution and solid state structures (except 5) of all complexes were determined by NMR spectroscopy and X-ray crystallography.     

Two different 1D-chains in the structures of the copper(I) coordination polymers based on bidentate Schiff-base building units and thiocyanate anions as bridging ligands

The reaction of the bidentate Schiff-base ligands (3,4,5-MeO-ba)₂en (L¹) and (4-Me-ba)₂en (L²) with Cu(SCN) in CH₃CN yielded two copper(I) coordination polymers [Cu(L¹)(SCN)]_n (1) and [Cu(L²)(SCN)]_n (2), which have been characterized by elemental analyses, IR- and ¹H NMR-spectroscopy, and X-ray crystallography. The non-centrosymmetric structures of both Cu(I) complexes consist of an one-dimensional polymeric chain in which copper(I) ions are bridged by two thiocyanate groups bonding in an end-to-end fashion. The Cu(I)?Cu(I) separation is 5.604 Å in 1 and 5.706 Å in 2.     

Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening

ContextSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that emerged late in 2019 is the etiologic agent of coronavirus disease 2019 (Covid-19). There is an urgent need to develop curative and preventive therapeutics to limit the current pandemic and to prevent the re-emergence of Covid-19. This study aimed to assess the in vitro activity of copper gluconate against SARS-CoV-2.MethodsVero E6 cells were cultured with or without copper gluconate 18−24 hours before infection. Cells were infected with a recombinant GFP expressing SARS-CoV-2. Cells were infected with a recombinant GFP expressing SARS-CoV-2. Infected cells were incubated in fresh medium containing varying concentration of copper gluconate (supplemented with bovine serum albumin or not) for an additional 48 -h period. The infection level was measured by the confocal microscopy-based high content screening method. The cell viability in presence of copper gluconate was assessed by XTT and propidium iodide assays.ResultsThe viability of Vero E6 cells exposed to copper gluconate up to 200 μM was found to be similar to that of unexposed cells, but it dropped below 70 % with 400 μM of this agent after 72 h of continuous exposure. The infection rate was 23.8 %, 18.9 %, 20.6 %, 6.9 %, 5.3 % and 5.2 % in cells treated prior infection with 0, 2, 10, 25, 50 and 100 μM of copper gluconate respectively. As compared to untreated cells, the number of infected cells was reduced by 71 %, 77 %, and 78 % with 25, 50, and 100 μM of copper gluconate respectively (p < 0.05). In cells treated only post-infection, the rate of infection dropped by 73 % with 100 μM of copper gluconate (p < 0.05). However, the antiviral activity of copper gluconate was abolished by the addition of bovine serum albumin.ConclusionCopper gluconate was found to mitigate SARS-CoV-2 infection in Vero E6 cells but this effect was abolished by albumin, which suggests that copper will not retain its activity in serum. Furthers studies are needed to investigate whether copper gluconate could be of benefit in mucosal administration such as mouthwash, nasal spray or aerosols.     

Biotransformation of dopamine to norlaudanosoline by Aspergillus niger

Norlaundanosoline is a key intermediate in the synthesis of the benzylisoquinoline alkaloids providing the upper isoquinoline portion of the morphinan skeleton. This study evaluates the feasibility of using Aspergillus niger as an in situ biotransformation system to produce norlaudanosoline from dopamine. A. niger was chosen because monoamine oxidase can be readily induced in this organism. Monoamine oxidase catalyzes the conversion of dopamine to 3,4-dihydroxyphenylacetaldehyde. In the presence of dopamine, this aldehyde will then undergo a spontaneous Picket-Spengler condensation to form norlaudanosoline. Fermentation condition to form norlaudanosoline. Fermentation conditions were optimized for the production monoamine oxidase by using a two-stage process consisting of a growth stage and an induction stage. pH control was found to be important, and at pH 4.5 dopamine accumulation in the cells was high as was the level of monoamine oxidase. With pH control at 4.5, up to 21% of the cellular dopamine was converted to norlaudanosoline. It is proposed that with further protein engineering improvements, this system may prove suitable for the in situ bio-transformation of dopamine to norlaudanosoline.